- Report
- October 2024
- 182 Pages
Global
From €3312EUR$3,545USD£2,802GBP
€3680EUR$3,939USD£3,113GBP
- Report
- April 2025
- 93 Pages
Global
From €5232EUR$5,600USD£4,426GBP
The Cystic Fibrosis Devices market is a subset of the larger Respiratory Devices market. It includes devices used to diagnose, monitor, and treat cystic fibrosis, a genetic disorder that affects the lungs and digestive system. Diagnostic devices include sweat chloride tests and genetic tests, while monitoring devices include spirometers and pulse oximeters. Treatment devices include nebulizers, inhalers, and airway clearance systems. These devices are used to help manage the symptoms of cystic fibrosis, such as coughing, wheezing, and difficulty breathing.
Some companies in the Cystic Fibrosis Devices market include Philips Respironics, ResMed, and Fisher & Paykel Healthcare. Other companies include Inogen, Invacare, and Vyaire Medical. Show Less Read more